Style | Citing Format |
---|---|
MLA | Boojar MMA, et al.. "New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line." Iranian Journal of Pharmaceutical Research, vol. 15, no. 3, 2016, pp. 421-433. |
APA | Boojar MMA, Hassanipour M, Mehr SE, Boojar MMA, Dehpour AR (2016). New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line. Iranian Journal of Pharmaceutical Research, 15(3), 421-433. |
Chicago | Boojar MMA, Hassanipour M, Mehr SE, Boojar MMA, Dehpour AR. "New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line." Iranian Journal of Pharmaceutical Research 15, no. 3 (2016): 421-433. |
Harvard | Boojar MMA et al. (2016) 'New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line', Iranian Journal of Pharmaceutical Research, 15(3), pp. 421-433. |
Vancouver | Boojar MMA, Hassanipour M, Mehr SE, Boojar MMA, Dehpour AR. New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line. Iranian Journal of Pharmaceutical Research. 2016;15(3):421-433. |
BibTex | @article{ author = {Boojar MMA and Hassanipour M and Mehr SE and Boojar MMA and Dehpour AR}, title = {New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {15}, number = {3}, pages = {421-433}, year = {2016} } |
RIS | TY - JOUR AU - Boojar MMA AU - Hassanipour M AU - Mehr SE AU - Boojar MMA AU - Dehpour AR TI - New Aspects of Silibinin Stereoisomers and Their 3-O-Galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 Hepatocarcinoma Cell Line JO - Iranian Journal of Pharmaceutical Research VL - 15 IS - 3 SP - 421 EP - 433 PY - 2016 ER - |